These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Age-related changes in the endocannabinoid system in the mouse hippocampus. Piyanova A; Lomazzo E; Bindila L; Lerner R; Albayram O; Ruhl T; Lutz B; Zimmer A; Bilkei-Gorzo A Mech Ageing Dev; 2015 Sep; 150():55-64. PubMed ID: 26278494 [TBL] [Abstract][Full Text] [Related]
43. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study. Chester LA; Englund A; Chesney E; Oliver D; Wilson J; Sovi S; Dickens AM; Oresic M; Linderman T; Hodsoll J; Minichino A; Strang J; Murray RM; Freeman TP; McGuire P Cannabis Cannabinoid Res; 2024 Feb; 9(1):188-198. PubMed ID: 36493386 [No Abstract] [Full Text] [Related]
44. Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. Luchicchi A; Pistis M Mol Neurobiol; 2012 Oct; 46(2):374-92. PubMed ID: 22801993 [TBL] [Abstract][Full Text] [Related]
45. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Maccarrone M; Finazzi-Agró A Cell Death Differ; 2003 Sep; 10(9):946-55. PubMed ID: 12934069 [TBL] [Abstract][Full Text] [Related]
46. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. Soria-Gómez E; Matias I; Rueda-Orozco PE; Cisneros M; Petrosino S; Navarro L; Di Marzo V; Prospéro-García O Br J Pharmacol; 2007 Aug; 151(7):1109-16. PubMed ID: 17549045 [TBL] [Abstract][Full Text] [Related]
47. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. Hansen HH; Schmid PC; Bittigau P; Lastres-Becker I; Berrendero F; Manzanares J; Ikonomidou C; Schmid HH; Fernández-Ruiz JJ; Hansen HS J Neurochem; 2001 Sep; 78(6):1415-27. PubMed ID: 11579150 [TBL] [Abstract][Full Text] [Related]
48. FAAH and anandamide: is 2-AG really the odd one out? Di Marzo V; Maccarrone M Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720 [TBL] [Abstract][Full Text] [Related]
49. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Kirkham TC; Williams CM; Fezza F; Di Marzo V Br J Pharmacol; 2002 Jun; 136(4):550-7. PubMed ID: 12055133 [TBL] [Abstract][Full Text] [Related]
50. Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans. Feuerecker M; Hauer D; Gresset T; Lassas S; Kaufmann I; Vogeser M; Briegel J; Hornuss C; Choukèr A; Schelling G Alcohol Alcohol; 2012; 47(3):226-32. PubMed ID: 22278319 [TBL] [Abstract][Full Text] [Related]
51. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray. Almeida-Santos AF; Gobira PH; Rosa LC; Guimaraes FS; Moreira FA; Aguiar DC Behav Brain Res; 2013 Sep; 252():10-7. PubMed ID: 23714073 [TBL] [Abstract][Full Text] [Related]
52. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. Romigi A; Bari M; Placidi F; Marciani MG; Malaponti M; Torelli F; Izzi F; Prosperetti C; Zannino S; Corte F; Chiaramonte C; Maccarrone M Epilepsia; 2010 May; 51(5):768-72. PubMed ID: 19817812 [TBL] [Abstract][Full Text] [Related]
53. Depolarizing and calcium-mobilizing stimuli fail to enhance synthesis and release of endocannabinoids from rat brain cerebral cortex slices. Sarmad S; Alexander SP; Barrett DA; Marsden CA; Kendall DA J Neurochem; 2011 May; 117(4):665-77. PubMed ID: 21375532 [TBL] [Abstract][Full Text] [Related]
54. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. Quercioli A; Pataky Z; Vincenti G; Makoundou V; Di Marzo V; Montecucco F; Carballo S; Thomas A; Staub C; Steffens S; Seimbille Y; Golay A; Ratib O; Harsch E; Mach F; Schindler TH Eur Heart J; 2011 Jun; 32(11):1369-78. PubMed ID: 21303779 [TBL] [Abstract][Full Text] [Related]
55. Endocannabinoid Anandamide Mediates the Effect of Skeletal Muscle Sphingomyelins on Human Energy Expenditure. Heinitz S; Basolo A; Piomelli D; Krakoff J; Piaggi P J Clin Endocrinol Metab; 2018 Oct; 103(10):3757-3766. PubMed ID: 30113648 [TBL] [Abstract][Full Text] [Related]
56. Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. Annuzzi G; Piscitelli F; Di Marino L; Patti L; Giacco R; Costabile G; Bozzetto L; Riccardi G; Verde R; Petrosino S; Rivellese AA; Di Marzo V Lipids Health Dis; 2010 Apr; 9():43. PubMed ID: 20426869 [TBL] [Abstract][Full Text] [Related]
57. Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex. Sticht MA; Limebeer CL; Rafla BR; Abdullah RA; Poklis JL; Ho W; Niphakis MJ; Cravatt BF; Sharkey KA; Lichtman AH; Parker LA Neuropharmacology; 2016 Mar; 102():92-102. PubMed ID: 26541329 [TBL] [Abstract][Full Text] [Related]